Dr Genghis Lloyd-Harris, Partner, Abingworth Management Ltd
Vincent Mutel, CEO, Addex Pharmaceuticals Ltd
Dr Karl Nägler, Principal, Atlas Venture
Jesper Zeuthen, Managing Director, BankInvest Biomedical Venture
Lubor Gaal, Executive Director, Head of Europe, Strategic Transactions Group, Bristol-Myers Squibb
Karl Keegan, Managing Director, Life Sciences Analyst, Canaccord Adams
Ms. Stephanie Léouzon, Managing Director Healthcare, Credit Suisse
Massimo Radaelli, President & CEO, Dompé International SA
Dimitri F. Dimitriou, Chief Executive Officer, DyoDelta Biosciences
Geoffroy de Ribains, Analyst, Edmond de Rothschild Investment Partners
Dr Xavier Pagès, Director, International Affairs, Business Development & Licensing, Esteve
Michèle Ollier, Principal, Index Ventures
Roel Bulthuis, Senior Director, Head of Merck Serono Ventures, Merck Serono International
François Conquet, Director Early Stage Licensing, Merck Serono International
Dr Margaret Beer, Senior Director and Head, Licensing and External Research, Europe, Merck & Co
Anthony Hartley, Executive Director, Morgan Stanley | Investment Banking Division
Markus Ewert, Global Head, Search & Evaluation, Novartis Pharma AG
Dr Ulrik Spork, Senior Partner, Novo Ventures A/S
Alex Chanas, Senior Director, Worldwide Licensing and Business Development, Pfizer Inc.
Dr Fintan Walton, CEO, PharmaVentures Ltd
Dr Paolo Bessieres, CEO, PharmaWave Ltd
Nigel Sheail, Vice President, Global Head Licensing, Pharma Partnering, Roche Pharmaceuticals
Laurent Feniou, Director, Rothschild
Rudy Tubbeh, Managing Director, Sager Pharma Kft.
Antoine Papiernik, Managing Partner, Sofinnova Partners
Yvonne Gunsch-Wegmann, Vice President, Head of Issuer & Investor Relations, SIX Swiss Exchange
Karen Wagner, PhD, Venture Partner, Ysios Capital Partners SGECR SA
*to be confirmed